lilly asia ventures

China-US biotech startup raises money for flu drug

Lilly Asia Ventures, Oceanpine Capital, Matrix Partners China are betting on Ansun BioPharma to kill the virus on your respiratory tract.

October 14, 2019

Backed by Lilly Asia Ventures and Hillhouse, Elpiscience wants to attract more funding to develop the best-in-class solution for cancer treatment.

July 07, 2019